« previous next »
Pages: [1]

Author Topic: Dimethyl fumarate (Tecfidera) and liver injury research information (PubMed)  (Read 163 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
Dimethyl fumarate (Tecfidera) and liver injury research information (PubMed)
« on: October 29, 2019, 07:28:38 pm »

Tecfidera (dimethyl fumarate) has a "likelihood score" of C ("probable rare cause of clinically apparent liver injury") in the Overview section about it in LiverTox: Clinical and Research Information on Drug-Induced Liver Injury issued by the National Institute of Diabetes and Digestive and Kidney Diseases, recently indexed in Pub Med.

https://www.ncbi.nlm.nih.gov/books/NBK548484/#DimethylFumarate.OVERVIEW
« Last Edit: October 29, 2019, 07:32:33 pm by agate »
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
80 Views 		Last post October 25, 2019, 07:56:09 pm
by agate
0 Replies
160 Views 		Last post October 26, 2019, 03:31:32 pm
by agate
0 Replies
100 Views 		Last post October 26, 2019, 03:36:52 pm
by agate
0 Replies
139 Views 		Last post October 26, 2019, 03:38:12 pm
by agate
0 Replies
145 Views 		Last post October 28, 2019, 04:12:17 pm
by agate